在超重患者中洗净微生物群移植的长期疗效
Dejiang Lin1,2, Dongxia Hu2, Youlin Song2
1School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
European journal of clinical investigation
|June 10, 2024
概括
洗微生物群移植 (WMT) 通过恢复肠道微生物群平衡,有效地减少长期超重个体的体重指数 (BMI). 这种治疗也显示出改善心血管疾病风险因素的希望.
科学领域:
- 微生物学 微生物学
- 代谢健康 代谢健康
- 胃肠病学 胃肠病学
背景情况:
- 便微生物群移植 (FMT) 是一个有前途的方法来管理肥胖和脂肪积累.
- 洗微生物种移植 (WMT) 是一种正在研究其治疗潜力的特定形式的FMT.
研究的目的:
- 评估WMT在超重患者的长期有效性.
- 评估WMT对体重指数 (BMI),代谢参数和心血管疾病 (ASCVD) 风险的影响.
主要方法:
- 从WMT.治疗的患者的临床数据的回顾性分析.
- 在WMT之前和之后的BMI,血糖,血脂和血压的比较.
- 评估肠道微生物群组成变化和ASCVD风险分层.
主要成果:
- 在超重患者中,WMT显著降低了BMI,使体重状况正常化 (p < .001).
- 长期观察到BMI降低,与恢复肠道微生物群平衡相关 (p < .001).
- 在一年后,WMT在中高风险人群中显示出显著的ASCVD风险降级效应,而在低风险人群中没有增加风险.
结论:
- 在超重患者中,WMT有效地显著降低了BMI.
- 在长期内,WMT对BMI的有益影响是持续的.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


